| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/18/2003 | CA2478173A1 Novel method of highly sensitive nucleic acid analysis |
| 09/18/2003 | CA2478120A1 Contrast agents containing ferritin for magnetic resonance imaging and methods related thereto |
| 09/18/2003 | CA2478110A1 Novel fluorescent label compounds |
| 09/18/2003 | CA2478104A1 Quantitative trait loci and somatostatin |
| 09/18/2003 | CA2478102A1 Antigens and their use as diagnostics and vaccines against species of plasmodium |
| 09/18/2003 | CA2478096A1 Multiplex detection of biological materials in a sample |
| 09/18/2003 | CA2478032A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/18/2003 | CA2477980A1 Crystalline structure of human mapkap kinase-2 |
| 09/18/2003 | CA2476938A1 Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43 |
| 09/18/2003 | CA2476842A1 Enzymatic ligation-based identification of nucleotide sequences |
| 09/18/2003 | CA2476386A1 A plasma mass spectrometer |
| 09/18/2003 | CA2472119A1 Screening method for orthopoxvirus antivirals |
| 09/18/2003 | CA2457473A1 Device and methods for measuring the response of at least one cell to a medium |
| 09/17/2003 | EP1345137A1 Method and system for providing gene analysis information and authentication identification method |
| 09/17/2003 | EP1344837A1 Detection of human immunodeficiency virus type 1 |
| 09/17/2003 | EP1344836A2 Random array of micro-spheres for the analysis of nucleic acid using enzyme digestion |
| 09/17/2003 | EP1344835A2 Real-time nucleic acid detection processes and compositions |
| 09/17/2003 | EP1344834A2 Methods for the toxicity prediction of a compound |
| 09/17/2003 | EP1344833A2 Method for detecting staphylococcus aureus |
| 09/17/2003 | EP1344832A1 Methods and nucleic acids for the analysis of methylation within the gene melastatin |
| 09/17/2003 | EP1344822A1 Method of concentrating gene |
| 09/17/2003 | EP1344181A2 Method and device for selectively targeting cells within a three -dimensional specimen |
| 09/17/2003 | EP1344177A2 System and method for predicting chromosomal regions that control phenotypic traits |
| 09/17/2003 | EP1344064A2 Compositions and methods relating to prostate specific genes and proteins |
| 09/17/2003 | EP1344063A1 A screening assay for antagonists of human leukocyte receptors |
| 09/17/2003 | EP1344060A2 Process for determining target function and identifying drug leads |
| 09/17/2003 | EP1344055A1 Materials for enhancing staining of biopolymers in matrices |
| 09/17/2003 | EP1344042A2 Separation of x- and y-sperm cells |
| 09/17/2003 | EP1343918A2 Measuring viral reverse transcriptase activity |
| 09/17/2003 | EP1343917A2 Methods for isolation of dna from stool samples |
| 09/17/2003 | EP1343916A2 Nucleic acid amplification methods |
| 09/17/2003 | EP1343915A1 Specific mucin expression as a marker for pancreatic cancer |
| 09/17/2003 | EP1343914A2 Multiplexed protein expression and activity assay |
| 09/17/2003 | EP1343912A2 Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 09/17/2003 | EP1343911A2 Microarray method of genotyping multiple samples at multiple loci |
| 09/17/2003 | EP1343910A2 Assay for identification of a test compound |
| 09/17/2003 | EP1343908A2 Nucleic acid amplification |
| 09/17/2003 | EP1343900A2 Oxidoreductases |
| 09/17/2003 | EP1343897A2 Purified active hcv ns2/3 protease |
| 09/17/2003 | EP1343895A2 Streptococcus pyogenes antigens and corresponding dna fragments |
| 09/17/2003 | EP1343891A2 Colon cancer marker |
| 09/17/2003 | EP1343890A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/17/2003 | EP1343889A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 09/17/2003 | EP1343888A2 Regulation of human chemokine-like receptor |
| 09/17/2003 | EP1343887A2 Human transporter proteins, nucleic acid molecules encoding them, and uses thereof |
| 09/17/2003 | EP1343886A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 09/17/2003 | EP1343885A2 Molecules for disease detection and treatment |
| 09/17/2003 | EP1343884A2 Jfy1 protein induces rapid apoptosis |
| 09/17/2003 | EP1343877A2 Stable composition comprising a nuclease and a phosphatase |
| 09/17/2003 | EP1343876A2 Modulators of activity of g-protein-coupled receptor kinases |
| 09/17/2003 | EP1343875A2 Sugar beet genes involved in stress tolerance |
| 09/17/2003 | EP1343871A2 Isolation and use of solid tumor stem cells |
| 09/17/2003 | EP1343869A2 Detection of nucleic acid differences using combined endonuclease cleavage and ligation reactions |
| 09/17/2003 | EP1343868A1 Method for minimizing optical interference during antibiotic susceptibility readings in a microbiological analyzer |
| 09/17/2003 | EP1343822A2 Means for the diagnosis and therapy of ctcl |
| 09/17/2003 | EP1343818A1 Modified tachykinin receptors |
| 09/17/2003 | EP1343815A2 Antibacterial treatments |
| 09/17/2003 | EP1343812A1 Protein cluster ii |
| 09/17/2003 | EP1343524A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 09/17/2003 | EP1343520A2 New therapeutic uses of smr1 peptides |
| 09/17/2003 | EP1343519A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 09/17/2003 | EP1343491A2 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy |
| 09/17/2003 | EP1343371A1 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 09/17/2003 | EP1266035A4 Improved methods for generating catalytic proteins |
| 09/17/2003 | EP1242627B1 Method and device for detecting and quantifying biomolecules |
| 09/17/2003 | EP1161557B1 Determination of the chemosensitivity via the caspase activity |
| 09/17/2003 | EP1159454B1 Polynucleotide sequencing method |
| 09/17/2003 | EP1088102B8 Pcr primer constructs for use in an integrated signaling system |
| 09/17/2003 | EP0981627B1 Purified telomerase |
| 09/17/2003 | EP0958383B1 Production of a lampbrush chromosome |
| 09/17/2003 | EP0724647A4 Nucleic acid ligands and improved methods for producing the same |
| 09/17/2003 | EP0697888B1 Conserved motif of hepatitis c virus e2/ns1 region |
| 09/17/2003 | CN2574056Y Hepatitis B virus mutational site oligonucleotide testing chip |
| 09/17/2003 | CN1443244A Enzyme detection and measurement |
| 09/17/2003 | CN1443241A Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, proteins encoded, and uses thereof |
| 09/17/2003 | CN1443240A Interferon-like protein zcyto 21 |
| 09/17/2003 | CN1443239A Compositions and methods for therapy and diagnosis of breast cancer |
| 09/17/2003 | CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 09/17/2003 | CN1443189A Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 09/17/2003 | CN1443187A Fused cyclic compounds as modulators of nuclear hormone receptor function |
| 09/17/2003 | CN1443085A Method for locating compounds which are suitable for treatment and/or prophylaxis of obesity |
| 09/17/2003 | CN1442693A Inspection method of foreign substance origenated from biological body |
| 09/17/2003 | CN1442488A Composite fluorescent quantitative PCR detection of SARS virus |
| 09/17/2003 | CN1442487A Kynurenine hydrolase polymorphism and its diagnostic use |
| 09/17/2003 | CN1442486A Method and device for identifying pathogenic influence of concurrent bacteria infection against poultry influenza virus infection |
| 09/17/2003 | CN1442485A Method and device for identifying pathogenic influence of concurrent bacteria infection against poultry influenza virus infection |
| 09/17/2003 | CN1442479A Mammalian engineering cell line for production of hantan virus granules |
| 09/17/2003 | CN1442424A Nucleotide specific against 0-antigen of colibacillus 0172 |
| 09/17/2003 | CN1442423A Nucleotide specific against 0-antigen of colibacillus 0107 |
| 09/17/2003 | CN1442422A Nucleotide specific against 0-antigen of shigella dysenteria 3, colibacillus 0124 and 0164 |
| 09/17/2003 | CN1442421A Nucleotide specific against o-antigen of colibacillus 0150 |
| 09/17/2003 | CN1442203A SARS crown virus and AIDS virus (HIV-1)-CD 147 acceptor target antagonist |
| 09/17/2003 | CN1442201A Compound containing osteoclast formation inhibiting factor and polysaccharide |
| 09/17/2003 | CN1442039A Molecular label closely linked with wheat gibberellin resistance main effect QTL and its application |
| 09/17/2003 | CN1121614C Automated molecular biological diagnostic system |
| 09/17/2003 | CN1121441C Method of detecting lung disease |
| 09/16/2003 | USRE38252 Corn cDNA encoding southern leaf blight resistance |
| 09/16/2003 | US6620923 Use for treatment of uterine cancer |
| 09/16/2003 | US6620915 Monoclonal antibodies specific for integrin α-d subunit |
| 09/16/2003 | US6620913 Polypeptides of a novel hantavirus |